Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO
Recruiting
Observational Study
Lung Transplant Failure and Rejection
Lung Transplant Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 146 (estimated)
- Sponsor
- Jesper Magnusson · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
LTx has the shortest survival of all solid organ transplants. The complex and time-demanding diagnostics of allograft dysfunction are a significant reason for this.
The current study aims overarchingly to improve survival after lung transplantation (LTx) through precise and fast diagnostics. The specific aim is to develop direct-to-clinical implementation biomarkers for the most important aspects…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Luing Transplanted and followed up within the reach of the study paricipating centres.
A good understanding to read and write within the languages in which the consent is provided.
Exclusion Criteria:
* Not Lung Transplanted or not followed up within the reach of the study …
Contacts